about
Long Noncoding RNA Regulation of PluripotencyGenetic background affects induced pluripotent stem cell generationRapamycin induces pluripotent genes associated with avoidance of replicative senescenceProgress and bottleneck in induced pluripotencyLIF-dependent signaling: new pieces in the Legop53 Suppression partially rescues the mutant phenotype in mouse models of DiGeorge syndrome.Self-renewal and pluripotency acquired through somatic reprogramming to human cancer stem cellsGenomic instability in iPS: time for a breakTransient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damageEnhancing the efficiency of direct reprogramming of human primary fibroblasts into dopaminergic neuron-like cells through p53 suppression.Gene expression profiles resulting from stable loss of p53 mirrors its role in tissue differentiation.Cell-free extract from porcine induced pluripotent stem cells can affect porcine somatic cell nuclear reprogrammingCooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells.Loss of p53 exacerbates multiple myeloma phenotype by facilitating the reprogramming of hematopoietic stem/progenitor cells to malignant plasma cells by MafB.A three-state model of telomere control over human proliferative boundaries.Stacking the DEK: from chromatin topology to cancer stem cells.Embryonic stem cells and inducible pluripotent stem cells: two faces of the same coin?Recent discoveries in the cycling, growing and aging of the p53 fieldRibosomal and hematopoietic defects in induced pluripotent stem cells derived from Diamond Blackfan anemia patients.Regulatory non-coding RNAs in pluripotent stem cells.Pharmacological activation of p53 in cancer cellsDevelopment Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cellsMicroRNA-based discovery of barriers to dedifferentiation of fibroblasts to pluripotent stem cells.The emerging functions of the p53-miRNA network in stem cell biology.Technological overview of iPS induction from human adult somatic cells.Toward directed reprogramming through exogenous factors.Pluripotency transcription factors in the pathogenesis of colorectal cancer and implications for prognosis.Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.The concept of radiation-enhanced stem cell differentiationReprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotencyHematopoietic cells as sources for patient-specific iPSCs and disease modeling.Roles of p53 and ASF1A in the Reprogramming of Sheep Kidney Cells to Pluripotent CellsEnhanced Response of Metformin towards the Cancer Cells due to Synergism with Multi-walled Carbon Nanotubes in Photothermal Therapy.Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance.p53: Guardian of pancreatic epithelial identity.Putting p53 in Context.Heme oxygenase-1 affects generation and spontaneous cardiac differentiation of induced pluripotent stem cells.Human Induced Pluripotent Stem (hiPS) Cells from Urine Samples: A Non-Integrative and Feeder-Free Reprogramming Strategy.Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.
P2860
Q26772311-07FD20C3-BB6E-427D-9FA7-0AB3CA9ACECEQ27499837-E9C51873-3515-42D2-8820-F6B6C87248B0Q28572137-3388529A-6532-4490-BDA9-DEA5A3A0BA4AQ28652287-4B96FA9C-4605-4E25-9CAD-70A000BDA750Q28731796-720BB8F4-733F-4A5B-AD50-C7F43E0B001BQ34218341-254D025B-B4FD-440E-BA6B-49E0D51674D9Q34473615-A582D138-3490-4D92-A7D7-4E863F4C2610Q34699718-B1562BD5-D195-4079-91F7-996739C655B5Q34699757-E33321F0-7455-4288-805D-B6B63C8AB9C0Q34887206-EA10DDF9-487C-4FC2-AA15-46E907F64E43Q35060929-CEB24CEF-B2C2-474D-AE15-BC9D402CFE61Q35539270-89EA8E30-3387-4979-A255-509D3A9D7407Q35640301-D33BA558-CE4F-4F57-876E-86C4FD28E318Q36392184-9BB4A0DF-B6BB-4526-9EF0-B310A33BA57EQ36494808-622B50E2-54C8-4DA9-B6CC-091B19E0E43BQ36604651-69EE9052-7FE4-409A-AEBC-E3DC4C464141Q36736355-C1DF1369-CF90-4ED9-84FB-E6C26C813F2CQ36736358-45D093AF-90F1-4E1B-8178-807D1DEAD725Q37083952-A8741157-64EE-423B-B675-A8609AD09C60Q37091955-34BBC500-101C-405C-B701-2203F73020CDQ37191174-944393E8-EDE1-42EE-96B2-0F8D8119DCFAQ37338044-49CEBCBE-C559-4B0F-9666-2DBDE38ACE2FQ37417024-62D4137C-3802-489B-AE46-7598173864C6Q37639005-5CC4C147-CD54-48FB-AEA5-E32FDB511F47Q38009641-64A459FE-0987-42F3-B2C0-CD9616550642Q38074176-CB7CD04A-4DFF-4F35-9AA9-08E9C3ABB0E6Q38127978-0F5CD1A6-6EF9-4008-A35C-464749E84886Q38390837-94747F3B-A705-4607-B4FB-ED3629AC4E99Q38418048-840BF587-F0E2-4E99-9C93-5F300EF8141FQ38591999-C0949F68-98CD-4D82-8818-8275CA5A3697Q38632891-B3AF98FA-10EF-402B-82BD-DC786088E61EQ39177276-13F2F26B-52DD-4DF4-9735-479153DC1D80Q41116367-26FA76A4-352F-498E-9FCA-337284D0B41DQ41822613-86911282-3778-434C-836A-BA4C021791AEQ42700778-CC7BD24D-5B82-4362-B80B-3E2795B5E9E0Q43006061-616593E5-3E9C-441B-AC9E-669D085298A0Q47833426-385E9A93-F2C5-4F80-92AE-DA4366A4F893Q48279499-2ADE6989-28AB-49A3-91C2-2C912F4F1ED9Q48873848-7CA57090-EED9-4A1B-A1EC-4EC234DCDE92Q51079814-0072BC64-0750-45DA-8476-4AE511BEC99D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
p53: guardian of reprogramming.
@en
p53: guardian of reprogramming.
@nl
type
label
p53: guardian of reprogramming.
@en
p53: guardian of reprogramming.
@nl
prefLabel
p53: guardian of reprogramming.
@en
p53: guardian of reprogramming.
@nl
P356
P1433
P1476
p53: guardian of reprogramming.
@en
P2093
Sergio Menendez
Suzanne Camus
P304
P356
10.4161/CC.9.19.13301
P577
2010-10-09T00:00:00Z